CA2258966A1 - High pressure transluminal fluid delivery device - Google Patents

High pressure transluminal fluid delivery device Download PDF

Info

Publication number
CA2258966A1
CA2258966A1 CA002258966A CA2258966A CA2258966A1 CA 2258966 A1 CA2258966 A1 CA 2258966A1 CA 002258966 A CA002258966 A CA 002258966A CA 2258966 A CA2258966 A CA 2258966A CA 2258966 A1 CA2258966 A1 CA 2258966A1
Authority
CA
Canada
Prior art keywords
delivery device
fluid
fluid delivery
coil
tubular housing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002258966A
Other languages
French (fr)
Inventor
J. Richard Spears
Philip S. Levin
Paul J. Zalesky
Vincent Divino Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Therox Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2258966A1 publication Critical patent/CA2258966A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0057Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M2025/0073Tip designed for influencing the flow or the flow velocity of the fluid, e.g. inserts for twisted or vortex flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/09058Basic structures of guide wires
    • A61M2025/09083Basic structures of guide wires having a coil around a core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/09058Basic structures of guide wires
    • A61M2025/09083Basic structures of guide wires having a coil around a core
    • A61M2025/09091Basic structures of guide wires having a coil around a core where a sheath surrounds the coil at the distal part
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/091Guide wires having a lumen for drug delivery or suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/09175Guide wires having specific characteristics at the distal tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0108Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M25/09016Guide wires with mandrils
    • A61M25/09033Guide wires with mandrils with fixed mandrils, e.g. mandrils fixed to tip; Tensionable wires

Abstract

The present invention includes a fluid delivery device (100) capable of delivering perfusion or other fluids to a vascular site. Preferred embodiments permit delivery of large quantities of fluid without causing recoil of the device, and without causing trauma to the vascular site.

Description

CA 022~8966 1998-12-22 W O 97149447 PCTrUS97/10919 ~igh Pressure Transluminal Fluid Delivery Device ~ ~hATED APPLIC~TION
~ The present appllcation is a continuation in part of Application Serial Number 08/~63,057, filed November 27, 1995, entitled "High Pressure Perfusion Device". Application Serial Number 08/563,0~7 is incorporated herein ~y reference.
10 FIEI.D OF THE lNV~ l'lON
The present invention relates generally to medical devices for the delivery of fluids transluminally, and more particularly to a high pressure perfusion device capable of delivering fluids atraumatically.
BACRG~O~ND
Various medical procedures require fluids to be delivered to specific locations within the body, typically via a fluid delivery catheter. A narrow steerable guidewire 20 is often used to maneuver through narrow, tortuous, and/or branching body passageways. After the guidewire has been directed to the desired location, a fluid delivery catheter may be inserted over the guidewire. The guidewire is usually removed before fluid delivery begins. Guidewires which are 25 themselves capable of fluid delivery (such as that disclosed in U.S. Patent 5,322,508) are also known in the art.
In current angiographic procedures, a relatively large (5 ~rench (1.65 mm) or larger) catheter is used to inject a contrast material into vascular spaces, such as the 30 coronary arteries and cerebral vessels. Contrast material is a radiopaque liquid typically including iodine or an equivalent component, and having a viscosity 2-10 times that of water. During or after injection of the radiopaque contrast material, an x-ray or fluoroscopic image is taken of 3~ the injection site.
Large angiographic catheters are typically required to perform such procedures because of the relatively high CA 022~8966 1998-12-22 W097/49447 PCT~S97/10919 viscosity of commonly used contrast materials, and because of the relatively large amount of contrast material required to produce a good quality angiographic image. But even when relatively large catheters are used, the contrast material s must be delivered under high pressure to ensure that a sufficient quantity of contrast material is delivered.
When contrast material is injected at a rate necessary to perform coronary angiography selectively into either the right or left coronary artery, the relatively high 10 velocity associated with the injection frequently results in recoil of the catheter, so that the contrast material may ~e injected into the aorta rather than selectively into the coronary artery, The relatively high velocity of contrast material injection also increases the potential for inducing 15 mechanical trauma to the inner surface of a ~lood vessel.
Accordingly, angiographic catheters smaller than about 5 French are not ordinarily suita~le for use in such procedures ~ecause of the even higher velocities required to inject a sufficient quantity of contrast material.
The use of conventional angiographic catheters presents other pro~lems as well. ~or example, a guidewire is usually needed to advance the catheter from the peripheral arterial access site to a location of interest. This guidewire is then removed from the lumen of the catheter to 25 allow the injection of contrast material through the same lumen. The use of both a wire and a catheter requires time for preparation and removal, and the overall cost of the equipment is increased ~y the need for two devices for each procedure. Moreover, in coronary angiographic procedures, 30 the right and left coronary arteries usually require catheter tips having different shapes to facilitate engagement of the ostium of the coronary artery with the distal tip of the catheter.
Accordingly, there remains a need in the art for an 3~ inexpensive, low profile, easy to use catheter or f~uid delivery device that can deliver large amounts of contrast CA 022~8966 1998-12-22 W097l49447 PCT~S97/10919 material without causing trauma to vascular walls, and without causing recoil of the catheter itself.
In angioscopy procedures, a fiberoptic angioscope positioned with a guide catheter is used to image the 5 interior of a blood vessel. To produce a clear image, the - blood within the vessel is displaced, usually with a transparent saline solution. Current angioscopy products, such as the ImageCath~ coronary angioscope by Guidant Corporation, include an angioscope within an outer catheter 10 that provides a balloon to stop antegrade blood flow, and saline to displace blood within a vessel.
While the Guidant device wor~s for its intended purpose, the relatively large profile of the outer catheter (4.~ ~rench, or approximately 1.5 mm) requires the use of a 15 very large (8 French, or approximately 2.6 mm) guide catheter to deliver the Guidant device to the desired location. The requirement for such a large guide catheter makes the Guidant angioscope difficult or impossible to use in certain locations, such as narrow or tortuous vessels. Accordingly, 20 there remains a need in the art for a low profile angioscopy device that can be used to image areas accessible through narrow or tortuous blood vessels.
During balloon angioplasty procedures, a catheter equipped with a small balloon is inserted (usually over a 25 guidewire) into an artery that has been narrowed, typically by the accumulation of fatty deposits. The balloon is then inflated to clear the blockage or lesion and widen the artery. Upon balloon inflation, blood flow distal to (that is, "downstream" from) the inflated balloon may be almost 30 completely stopped.
Myocardial ischemia (that is, a reduction in ~lood perfusion to the heart muscle) occurs transiently in the majority of patients undergoing coronary angioplasty procedures, such as balloon angioplasty, directional 3~ atherectomy, rotational atherectomy, and stent deployment.
The permissible duration of occlusion due to balloon inflation or other device deployment is norma~ly determined CA 022~8966 1998-12-22 W 097/49~47 PCTrUS97/10919 by the severity of myocardial ischemia. Typically, evidence of severe ischemia (including patient chest pain and ECG
changes) requires that the operator deflate the balloon or remove the occlusive device after approximately 60 to 120 s seconds. For anatomically difficult lesions, such as type B
and C lesions, longer periods of ~alloon inflation (or other device deployment) are frequently desira~le for the first balloon inflation or other device deployment.
Autoperfusion ~alloon catheters, and catheters of 10 the type disclosed in U.S. Patent 5,322,508, can in some circumstances allow longer periods of ~alloon inflation.
~owever, the ~lood (or other physiologic liquid) flow through such devices is frequently insufficient to provide an adequate oxygen supply to tissues distal to the angioplasty 15 balloon or other occlusive device.
~ ecent advances in the generation and application of oxygen supersaturated solutions have made it possi~le to deliver greater amounts of oxygen to tissues distal to an angioplasty balloon. U.S. Patent 5,407,426, and pending 20 applications serial no. 08/273,652, filed 7/12/94, entitled "Method for Delivering a Gas-Supersaturated Fluid to a Gas-Depleted Site and Use Thereof"; 08/353,137, filed 12/9/94, entitled "Apparatus and Method of Delivery of Gas-Supersaturated Liquids"; 08/453,660, filed 5/30/95,'entitled 25 "Method for Delivering a Gas-Supersaturated fluid to a Gas-Depleted Site and Use Thereof"; 08/465,425, filed 6/5/95, entitled "Method for Delivery of Gas-Supersaturated Liquids";
08/484,279, filed 6/7/95, entitled "Apparatus and Method of Delivery of oxygen-Supersaturated Physiologic Solutions 30 During Clinical Procedures"; and 08/484,284, filed 6/7/95, entitled "High ~ressure Gas ~xchanger", which are incorporated herein ~y reference, disclose various methods for the generation and application of oxygen supersaturated liquids.
3s As is described in the a~ove referenced patent applications, the generation, transport and delivery of oxygen supersaturated liquid may require the application of CA 022~8966 1998-12-22 W 097149447 PCTrUS97/10919 very high hydrostatic pressures. Accordingly, there remains a need for a high pressure fluid delivery device capable of infusing ~ub~le-free fluid, which is supersaturated with oxygen, to vessels or ducts through and beyond the central 5 lumen of a balloon angioplasty catheter or similarly occlusive device.

S~MN~RY
Preferred em~odiments of the present invention meet 10 the a~ove needs in the art by providing a guidewire device capable of delivering fluids to a vascular site, while at the same time exhibiting handling characteristics associated with existing non-perfusion guidewires so that additional education or retraining of operators is reduced or 15 eliminated.
Preferred embodiments of the invention further meet these needs ~y providing a relatively low profile fluid delivery device capa~le of delivering relatively large quantities of contrast material or other fluid to a desired 20 vascular location without causing trauma to the vasculature, and without causing significant recoil of the delivery device.
Preferred embodiments of the present invention also provide a perfusion guidewire which closely matches~the 25 dimensions and physical characteristics of standard guidewires in diameter, length, flexibility, column strength, torque transfer, surface friction, kink resistance, radiopacity (i.e., opacity to x-rays), non-throm~ogenicity (i.e., tendency not to promote blood clots) and bio-30 compatibility. Preferred embodiments of the invention permit high pressure perfusion of any desirable liquid, and also include a liquid flow path that will not promote bu~ble generation or growth, or destabilize an oxygen supersaturated solution.
A high pressure perfusion guidewire according to the invention preferably includes two or three sections: a tu~ular proximal segment or handle, which comprises the CA 022~8966 1998-12-22 greater part of the perfusion guidewire length; an (optional) transitional region which provides the desired torque transfer and pressure drop characteristics; and a distal segment which conveys the fluid out of the perfusion 5 guidewire at a relatively low velocity, and also mimics the distal functions of a standard guidewire.
The proximal segment may be connected to a fluid source using standard or specialized connectors capable of withstanding the required fluid pressures.
BRIEF DESCRIPTION OF TH~ DRAWINGS
FIG. 1 shows a transluminal fluid delivery system including a high pressure perfusion device according to a preferred em~odiment of the invention;
FIG. 2 is a cross sectional view of the proximal portion of a high pressure perfusion device according to the invention;
FIG. 3 is a cross sectional view of the transitional region of a high pressure perfusion device 20 according to the invention, continued from FIG. 2;
FIG. 4 is a cross sectional view of the transitional region of an alternative embodiment of a high pressure perfusion device according to the invention, also continued from FIG. 2;
FIG. 5 is a cross sectional view of the transitional region of a second alternative em~odiment of a high pressure perfusion device according to the invention, also continued from ~IG. 2;
~IG. 6 is a partial cross sectional view of the 30 distal segment of a high pressure perfusion device according to the invention, continued from either of FIGS. 3, ~ or 5;
FIG. 7 is a partial cross sectional view of the transitional region and distal segment of an alternative perfusion device according to the invention;
FIG. 8 is a partial cross sectional view of circled portion 150 of the distal segment shown in FIGS. 7 and 14;

CA 022~8966 1998-12-22 W 097/49447 PCTrUS97/10919 FI&. 9 is a partial cross sectional view of the transitional region and distal segment of a second alternative perfusion device according to the invention;
FIG. 10 is a partial cross sectional view of 5 circled portion 139 of the distal segment shown in ~IG. 9;
~ IG. 11 is a partial cross sectional view of the transitional region and distal segment of a third alternative perfusion device according to the invention;
FIG. 12 is a partial cross sectional view of 10 circled portion 137 of the distal segment shown in FIGS. 11 and 20;
FIG. 13 is a partial cross sectional view of circled portion 112 of the transitional region shown in FIGS.
7, 9, and 11;
FIG. 14 is a partial cross sectional view of the transitional region and distal segment of a fourth alternative perfusion device according to the invention;
FIG. 15 is a partial cross sectional view of circled portion 148 of the distal segment shown in FIG. 14;
FIG. 16 is a partial cross sectional view of the transitional region and distal segment of a fifth alternative perfusion device according to the invention;
FIG. 17 is a partial cross sectional view of circled portion 114 of the transitional region show~ in FIG.
25 16; .
FIG. 18 is a partial cross sectional view of the distal segment of a sixth alternative perfusion device according to the invention;
FIG. 19 shows a reconfigurable fluid delivery 30 device and associated hardware according to a preferred embodiment;
FIG. 20 is a partial cross sectional view of the distal segment of the reconfigurable fluid delivery device of FIG. 19; and FIG. 21 is a partial cross sectional view of a guide catheter containing the distal segment of the perfusion device shown in FIG. 18 and an angioscopic optical bundle.

CA 022~8966 1998-12-22 W O 97/49447 PCT~US97110919 DET~TT~n DESC~IPTION
The structure and function of the preferred embodiments can best ~e understood by reference to the 5 drawings. The reader will note that the same reference numerals appear in multiple figures. Where this is the case, the numerals-refer to the same or corresponding structure in those figures.
The present invention includes several embodiments 10 of a high pressure fluid delivery device. As will be made clear below, the major differences between the various embodiments are in the transitional regions and distal segments. Persons of ordinary skill in the art will understand that the alternative regions or segments may ~e 15 used together in combinations other than described in detail below, ~ased on the teachings contained herein.

Transluminal ~luid Deli~ery System ~IG. 1 shows a transluminal fluid delivery system 20 100 according to a preferred embodiment. Fluid delivery system 100 includes a high pressure source 102, such as a pump or reservoir, a connector 70, a tube 104 connecting an output of high pressure source 102 to an input of connector 70, and a perfusion device or guidewire 108. Connector 70 25 may ~e a standard or specialized connector capable of withstanding the desired fluid ~ressures. As will be discussed further below, each embodiment of perfusion guidewire 108 includes a handle or proximal segment 10, a transitional region 20, and a distal segment 40.
Proximal Segment or Handle ~ eferring now to FIG. 2, a handle or proximal segment 10 of perfusion guidewire 108 is shown. Proximal segment 10 includes a thin-walled tube 12 which defines a 3s lumen. Tu~e 12 is made of bio-compati~le material, has the appropriate dimensions, and the appropriate burst strength, flexibility, torque transfer, and kink resistance CA 022~8966 1998-12-22 W 097/49447 rCT~US97/10919 characteristics for use as a perfusion device or guidewire as described herein. Tube 12 is prefera~ly coated over most of its length with a low friction, thin film bio-compatible coating 13, such as PTFE. Tube 12 also has an opening ~6 for 5 connection to a source of high pressure liquid, such as contrast material, saline, or oxygen supersaturated liquid.
In one embodiment which may be used as a perfusion guidewire, tube 12 of proximal segment 10 is prefera~ly a 304 stainless steel tube having a .0145" outside diameter, a 10 .010" inside diameter, and a length of approximately 150 cm.
Tube 12 preferably also has a .0004" to .0007" thick coating 13 of PTFE over its full length, except for a few cm at each end. In another embodiment, tube 12 of proximal segment 10 is a 304 stainless steel tube having a.0132" outside 15 diameter, a .008" inside diameter, and a length of approximately 150 cm. In this embodiment, tube 12 would also preferably have a .0004" to .0007" thick coating of PTFE over its full length, except for a few cm at each end. If necessary to avoid kin~ing during the initial part of a 20 procedure, a support wire or stylet (not shown) may be inserted in tube 12. The support wire or stylet may be withdrawn ~efore liquid is introduced into tube 12.

Transitional Region ~eferring now to ~IG. 3, one embodiment of a transitional region 20 of perfusion device or guidewire 108 is shown. Transitional region 20 provides a transition between tube 12 and the region defined by core wire 24 and sheath 26. The transitional region 20 also is designed to 30 achieve the objective of providing a perfusion guidewire with the handling characteristics of a "standard" guidewire.
"Standard" guidewire is used herein to refer to the typical non-perfusion guidewires commonly used today for various procedures. Such procedures may involve coronary or 3~ peripheral vessels. Examples of guidewires considered to be standard guidewires are shown in U.S. Patent Nos. 4,538,622 and 4,619,274. Based on the teachings contained herein, a g ... ,.. ,~ ....

CA 022~8966 1998-12-22 W097/49447 PCT~S97/10919 person of ordinary skill in the art may select the various parameters of the present invention to achieve handling characteristics substantially the same as those of the above guidewires, or any other handling characteristics desired for 5 a particular procedure.
In one embodiment, the distal end of tu~e 12 is ground or otherwise machined eccentrically so that a tapered lip 28 is created which resembles the nib end of a quill pen.
Alternatively, a separate lip may be secured to the end of 10 the tube. By way of example, for the tu~e 12 dimensions described above, lip 28 is preferably between about 1 and 5 cm long, and is preferably tapered smoothly to a final dimension of about .006" wide and about .001" thick. This "quill-like" lip 28 provides several advantages.
First, lip 28 provides a low resistance transition, since the transition from tube 12 to the region defined by core wire 24 and sheath 26 is accomplished with little or no decrease in cross-section flow area, and in some instances even net increase. Second, lip 28 provides a smooth flow 20 transition because lip 28 is tapered; there are no abrupt changes in the flow path geometry. These first two characteristics reduce the possibility that cavitation or bubble formation will take place in a supersaturated solution flowing through the guidewire. As a third advantage, lip 28 25 provides a convenient and strong attachment point for the distal core wire 24. Finally, lip 28 provides a joint between core wire 24 and tube ~2 which creates a smooth transition in terms of flexibility and stiffness. The taper of lip 28 may be easily adjusted to match any desired 30 flexibility profile. In particular, the taper may ~e adjusted to match the flexibility profile of a standard coronary guidewire.
An important element of guidewire design involves the transfer of torque from the proximal end of the 35 guidewire, where the physician manipulates the guidewire, to the distal end. A smooth, even rotary action is required of a guidewire, even in a tortuous vascular pathway. Because CA 022~8966 1998-12-22 W097/49447 PCT~S97/10919 lip 28 is not axially symmetric, it can exhibit a "cast" or unevenness in rotary motion when it is passed over a sharp bend. To reduce the cast, lip 28 is preferably sufficiently short in length and core wire 24 is long enough such that lip 5 28 is positioned proximal of any sharp bends in the vascular pathway during use. In practice, it is usually sufficient to locate lip 28 proximal of the aortic arch during a coronary angioplasty procedure.
~eferring now to ~IG. 4, an alternative embodiment 10 of transitional region 20 is shown. In procedures where transitional region 20 must encounter vascular tortuosity, or it is otherwise desirable to greatly reduce the cast, a lip 28A may be fashioned from the distal end of tube 12 into a helical form. Lip 28A will exhi~it more evenness in rotary 15 motion when passed over sharp bends than lip 28, but lip 28A
will still maintain the aforementioned advantages of the non-helical lip 28. Exemplary dimensions for lip 28A with the tubes described above are a~out ~ cm long, and tapered smoothly to a final dimension of about .006" wide and about 20 .001" thick.
~ eferring now to FI~. 5, a second alternative embodiment of transitional region 20 is shown. In the em~odiment shown in FI~. 5, the distal end of tube 12 is prefera~ly ground or fashioned so that the outside ~iameter 25 of tube 12 is reduced, while the inside diameter of tube 12 remains substantially the same. ~his forms a step 260 having a su~stantially annular opening defined by the inside diameter of step 260 and core wire 24. A sheath 26 is preferably attached to the reduced outside diameter of tube 30 12 along step 260 using a layer of epoxy 200. Step 260 facilitates the attachment of sheath 26 while maintaining an ~ outside diameter that is substantially the same along the length of the device. Alternatively, step 260 could be eliminated and sheath 26 could be attached directly to the 35 outside of tube 12.
Core wire 24 is ground at its proximal end to form an entrance taper 25 including a proximal extension 25A.

CA 022~8966 1998-12-22 W 097/49447 PCTrUS97/10919 Proximal extension 25A of core wire 24 is fiXed to a notch 262 in tu~e 12 using an appropriate solder or 3~raze alloy 264.
Step 260 prefera~ly has an outside diameter of 5 about .012", and proximal extension 25A prefera3~ly is .120"
long and has a diameter of .0057". Entrance taper 25 preferably has a diameter that ranges from .0055" to .0075".
Distal Segment FIG. 6 shows one embodiment of a distal segment 40 10 of perfusion guidewire 108. Distal segment 40 includes core wire 24, thin-walled sheath 26 and a distal coil or coil spring 42. The material properties and dimensions of distal segment 40 are prefera~ly selected to match the physical properties of standard guidewires.
In an exemplary em~odiment, sheath 26 comprises approximately 30 cm of high strength polymer tu~ing 54, having an outside diameter of a~out .0145", an inside diameter of about .0135", and approximately 4 cm of polyester heat shrink tul~ing 56 in the transitional and proximal 20 regions (See ~IGS. 2-4) having an approximate, unrecovered inside diameter of .017" and a wall thickness of a~out .0005". Tu~ing 54 is prefera~ly made of polyimide. At the proximal end of sheath 26, the polyimide tubing 54 is placed over lip 28 or 28A, to within 1 cm of the proximal ~nd of lip 28 or 28A. Polyester heat shrink tubing 56 forms a ~ridging joint between tube 12 and polyimide tubing 54. A thin epoxy film (not shown) is applied l~eneath heat shrink tu~ing 56, and then heat shrink tubing 56 is heat sealed to form a leak-free bond with tubing 12 and polyimide tubing 54.
In alternative embodiments (shown, for example, in ~IG. 5), sheath 26 comprises approximately 3S cm of hiyh strength polymer (preferably polyimide) tubing 54, having an outside diameter of al~out .01~5" and an inside diameter of about .0135". At the proximal end of sheath 26, tu~ing 54 is 35 placed over step 260. A thin epoxy film is applied ~eneath polyimide tu~ing 54 to form a leak-free ~ond with step 260.

CA 022~8966 1998-12-22 W 097/49447 PCT~US97/10919 The polyimide tubing 54 is preferably coated with a thin film of a lubricous hydrophilic coating. Appropriate hydrophilic coatings, such as BSI PV01/PVP, are well known to those skilled in the art.
At its distal end, polyimide tubing ~4 of sheath 26 may be open- or close-ended. If polyimide tubing 54 is close-ended, it may be configured with a number of sideports 55 or some such means to allow flow to exit sheath 26. The sideports 55 can be made as a plurality of perforations which 10 are typically between about 15-50 ~m in diameter, arranged along about a 2 cm length. The open end 52 of polyimide tubing 54 may be positioned over distal coil 42, or it may terminate before coil 42 as is shown in ~I&. 6.
Alternatively, the distal end of polyimide tubing 54 may 15 overlap distal coil 42 and be ~onded with epoxy to distal coil 42. Polyimide tubing 54 may also be attached to an exposed portion of core wire 24. If polyimide tubing 54 is open-ended, it may be terminated with a bevel or a square cut open end 52, and may also be configured with a number of 20 sideports 55. The actual configuration of the openings and total area can be selected by a person of ordinary skill based on the teachings herein.
As was discussed above, core wire 24 is attached at its proximal end to the distal end of lip 28 or 28A~(see 2~ ~IGS. 3 and 4) or to notch 262 in tube 12 (see ~I~. 5). At its distal end, core wire 24 is embedded at least partially into distal coil 42 as is known in guidewire construction.
Core wire 24 may have any appropriate cross-sectional shape, length and diameter.
In an exemplary preferred embodiment, core wire 24 is approximately 35 cm long with a circular cross section.
over the proximal 24 cm, core wire 24 has an outside diameter of about .006". It then tapers smoothly over an approximately 2 cm distance to an outside diameter of about 35 .005", and is constant at this diameter for approximately 5 cm. Core wire 24 then tapers down to an outside diameter of about .003", where it is embedded within distal coil 42.

CA 022~8966 1998-12-22 W O 97/49447 ~ PCTAUS97110919 Again, core wire 24 is ground at the proximal end to form an entrance taper 25 which provides a smooth flow transition (See FI~S. 3, 4, and 5).
Distal coil 42 serves as a compliant leading edge 5 for the atraumatic and formable guidewire. The requirements, construction and dimensions of distal coil 42 are well known to those skilled in the art. In a preferred em~odiment, distal coil 42 is 4 cm long with an outside diameter of .010"
to .014". Distal coil 42 is prefera~ly coated with a thin 10 film of an appropriate hydrophilic coating such as BSI
PVOltPVP. Distal coil 42 is also preferably radiopaque along its distal 2 cm, and may have a ~end or cast at its distal end to allow the physician to "steer" the guidewire along tortuous passageways.
The disclosed perfusion guidewire is preferably inserted and used in the same manner as a standard coronary guidewire using a conventional torquing handle (not shown).
As is ~nown to those skilled in the art, a torquing handle is a hollow tube with an annular screw-down clamp similar to the 20 chuck of a drill. It is slipped over the proximal end of the guidewire and screwed down to securely hold the guidewire to allow its manipulation. The preferred embodiments of the invention exhibit su~stantially the same performance characteristics as a standard guidewire, and can ~e'inserted 25 and used with conventional instrumentation and techniques.
For this reason, a perfusion guidewire according to the invention could be regularly substituted for a standard guidewire, so that in the event a perfusion need arises during a procedure, there is no need to exchange guidewires.
30 In a typical procedure using the present invention, the perfusion guidewire is inserted into the patient's vasculature and advanced to the treatment site using known techniques. This might involve crossing a lesion for application of ~alloon angioplasty. However, unlike standard 35 guidewires, when the vessel is occluded during a procedure, flow in the vessel can be maintained by perfusing fluid through the guidewire of the present invention.

CA 022~8966 1998-12-22 W 097/49447 PCTrU$97/10919 Other Alternative ~mbodiments As was discussed above, the present invention includes several em~odiments of perfusion device or guidewire 108. Several alternative embodiments of transitional region 20 and distal segment 40 will be discussed below. Also, dimensions provided herein are preferred dimensions for a particular size of device as described. Persons of ordinary skill in the art may appropriately size a device by modifying the preferred dimensions without departing from the scope of 10 the invention.

Transitional Region As was discussed above with respect to FIGS. 3, 4, and 5, transitional region 20 may include an elongated lip 28 15 or 28A, or a step 26~ which is formed from the distal end of tube 12. Alternatively, as is shown in ~IGS. 7, 9, 11, and 13, a lip 2BC may be formed from a separate tubular segment 110. Of course, lip 28C could take the form of lip 28 or 28A.
By making lip 28C out of a separate tubular segment 110, the segment distal to lip 28C can be made with a substantially smaller outside diameter than would otherwise be possible if the lip were made from tube 12. Circled region 112 in FIGS. 7, 9, and 11 is shown enlarged ~n ~IG.
2~ 13.
As is shown in ~IGS. 14 and 1~, tubular segment 110 may also include a second tapered lip 28D. Lip 28D provides a smooth transition from the larger inside diameter of tube 12 to the smaller inside diameter of tubular segment 110, and 30 thus minimizes turbulence. Circled region 114 of FIG. 14 is shown enlarged as ~IG. 1~.
~ Again, lips 28C and 28D may ~e fashioned into any desired shape. In cases where lip 28C or 28D must encounter vascular tortuosity, one or ~oth may be fashioned into a 3~ helical form, as was discussed above with respect to ~IG. 4.
Lips 28C and 28D provide the same advantages as discussed above with respect to lips 28 and 28A.

, CA 022~8966 1998-12-22 W O 97/49447 PCT~US97/10919 Tubular segment 110 is preferably a 304 stainless steel tube having an inside diameter of .005", an outside diameter of .0075", and a length of 5 cm. Lips 28C (and where applicable 28D), are preferably approximately 1 cm 5 long, and are preferably tapered smoothly to a final dimension of .006" wide by .001" thick.
In the embodiments shown in FIGS. 7, 9, 11, 13, 14, and 15, tubular segment 110 is typically joined to tube 12 and to stainless steel coil 116 with a lap joint 118 of an 10 appropriate solder or braze alloy. Tubular segment 110 is also sealed with an overcladding or sheath of polyimide tubing 54. Polyimide tubing 54 is in turn surrounded by stainless steel coil 116, which preferably has an inside diameter of .010" and an outside diameter of .014".
15 Polyimide tubing 54 can be sealed to tubular segment llo via a lea~ tight lap bond 122 made of epoxy.
As in the above described embodiments, a core wire 24 is ~onded to the distal end of lip 28C. Specifically, entrance taper 25 is preferably lap-joined with an 20 appropriate solder or braze alloy to the distal end of lip 28C with an overlap of approximately 1.5 mm. Again, core wire 24 may be coated with a thin film of an appropriate hydrophilic coating.

25 Distal Segment In the em~odiments shown in ~IGS. 7, 9, 11, and 14, distal segment 40 (i.e., the segment distal to lip 28C) generally includes core wire 24, a nonporous entrance region including tubing 54 and coil 116, a porous perfusion zone 125 30 including a baffle 126, and a standard floppy tip distal coil g2. Distal coil 42 is preferably separated from coil 116 by a solid solder joint 140. Baffle 126 provides a gradual pressure and flow velocity drop for high pressure fluids being perfused or delivered at a site of interest.
Fluid flows from transitional region 20 through tubing 54 (and around core wire 24) to baffle 126 in perfusion zone 125. Coil 116, which surrounds and supports CA 022~8966 1998-12-22 W 097/49447 PCT~US97/10919 tu~ing 54 and baffle 126, allows tubing 54 and baffle 126 to withstand high hydrostatic pressures.
The perfusion zone 125 is a porous region, prefera~ly about 1-6 cm in length, through which the 5 perfusion fluid is delivered. To effect "weeping" or low velocity flow, perfusion zone 125 includes porous baffle 126 surrounded by stainless steel coil 116. In general, porous baffle 126 can be any suitable structure which causes a flow velocity drop as the fluid exits, to convert high velocity 10 fluid flow (typically greater than 10 m/s) to a low velocity, or "weeping" flow. Baffle 126 preferably provides a flow velocity drop of at least a factor of five. The output of a low velocity, or "weeping" flow (as opposed to a flow including high velocity jets) from baffle 126 is atraumatic 15 in that it reduces the possi~ility that fluid delivered by the device or guidewire will damage nearby tissue. A low velocity, or "weeping" flow from ~affle 126 also reduces the possibility that cavitation or bubble formation will occur when a supersaturated fluid is delivered. As an example, at 20 an ambient pressure of a}~out 14.7 psi, an average blood pressure would be approximately 18 psi. Atraumatic pressure would }~e in this general range, but high enough to create flow. Prefera~ly, for most applications where a pressure (and velocity) drop is required, the exit pressure ~ill be 25 less than about 25 psi, and the exit velocity will be less than about 200 cm/sec.
Such a pressure drop can be an important factor when high pressures are utilized with oxygen supersaturated perfusion treatments in order to maintain the oxygen partial 30 pressure at sufficient levels downstream of a vessel-occluding procedure, such as balloon angioplasty. For example, in the delivery of oxygen supersaturated fluid according to the copending applications incorporated by reference herein, utilizing the present invention, it could 35 be necessary to apply pressures in excess of about 1000 psi (and potentially 10,000 to 15,000 psi or higher) to ensure sufficient fluid flow and adequate oxygenation. As an CA 022~8966 1998-12-22 W097/4g447 PCT~US97/10919 example, a flow of about 35 ml per minute with perfusion of a supersaturated fluid as described in the above referenced applications can provide approximately 2 cc of oxygen per minute downstream of the treatment site in order to ensure a 5 tissue oxygen partial pressure near acceptable levels (sustainable vessel blood flow rates typically are about 25 to 35 ml per minute in the large coronary arteries).
Depending on the particular application, flow rates may be as low as about 1 ml per minute. For coronary applications, 10 flow rates between about 10 and 50 ml per minute may be used and more specifically approximately 25 to 35 ml per minute.
oxygen can thus be delivered at rates between about 2 to 10 cc per minute and typically at least about 0.6 cc per minute.
Utilizing the present invention with oxygen supersaturated 15 fluids as described above can provide an oxygen partial pressure downstream of an occluding treatment site of at least about 7~0 mmHg and typically not less than about 1000 mmHg. Because of the high pressures that may be necessary to maintain adequate oxygen supply, the component~ of the 20 invention preferably have a burst strength of at least about 1000 psi or higher to match the anticipated maximum pressures.
As shown in FIG. 7, for example, porous baffle 126 is sealed to polyimide tube 54 so that no flow can ~ypass 25 porous baffle 126. Porous baffle 126 may be open or closed-ended, and preferably has length of at least approximately 2 cm. However, the length of baffle 126 may be tailored to suit the intended application, and it may be shorter than perfusion zone 125. Baffle 126 may include a polyimide tube 30 having a plurality of fluid exit ports, one or more layers of porous polycarbonate or polyester tubing, or a combination of polyimide and polycarbonate (or polyester) tubing within coil 116. These combinations will be discussed further below.
FIGS. 9 and 10 show a baffle 126A including a 35 perforated polyimide tube 130. FIG. lo is an enlarged view of the circled region 139 shown in FIG. 9. Tube 130 is perforated with a plurality of exit ports 132. Exit ports - ~8 -CA 022~8966 1998-12-22 W O 97/49447 PCTrUS97/10919 132 may be formed with a laser, and are prefera~ly each between 15-50 ~m in diameter. Polyimide tubing 130 is surrounded by coil 116, which supports polyimide tube 130 and allows it to withstand high hydrostatic pressure. Polyimide 5 tubing 130 may be bonded to polyimide tubing 54, or polyimide tubing 130 may be a continuous part of tu~ing 54. In one embodiment, the pressure of fluid exiting ports 132 causes the individual windings of coil 116 to spread apart, so that fluid may be delivered to a desired region. Alternatively, 10 the windings of coil 116 may be pre-tensioned, during the fabrication stage, to provide a fixed spacing between the windings of between 10 and 60 microns.
~ eferring now to FIGS. 11 and 12, a perfusion guidewire including a baffle 126B is shown. FI~. 12 is an 15 enlarged view of the circled region 137 shown in FIG. 11. In baffle 126B, polyimide tube 54 is bonded, preferably with epoxy, to a rolled porous membrane, sheet, or tu~e 133 having a first ply 134 and a second ply 136. A short tubular member 142 (preferably made of polyimide) may also be used to bond 20 polyimide tu~e 54 to rolled porous mem~rane 133. Porous membrane 133 may be any appropriate permea~le material, including polyester and polycarbonate, or could be a screen or mesh of any appropriate material. A layer of epoxy 144 can be used to bond porous membrane 133 and polyimide tube 54 25 to tubular mem~er 142. Plies 134 and 136 preferably have a 3 to 5 micron porosity, and are each about 6 microns thick. A
single ply of porous material could also be used if desired.
Additional plies of porous material will have the effect of further reducing the velocity of the delivered perfusion 30 fluid.
Again, fluid flows out from plies 134 and 136 and then passes through the windings of stainless steel coil 116.
The coils of stainless steel coil 116 may be spread apart by the hydrostatic pressure exerted ~y the fluid flowing from 35 the porous mem~rane 133, or the windings of coil 116 mzy be pre-tensioned, during the fabrication stage, to provide a . ~

CA 022~8966 1998-12-22 W O 97/49447 PCTrUS97/lOgl9 fixed spacing between the windings of between 10 and 60 microns.
~ eferring now to FIGS. 7, 8, and 14, a perfusion guidewire including a baffle 126C is shown. FIG. 8 is an 5 enlarged view of circled region 150 shown in FIGS. 7 and 14.
Baffle 126C preferably includes a first layer of perforated polyimide tu~ing 130 (including a plurality of exit ports 132) and a rolled porous membrane, tube, or sheet 133, having a first ply 134 and a second ply 136. As was discussed a~ove 10 with respect to the other em~odiments, polyimide tu~ing 54 may ~e bonded to tu~ing 130 and porous mem~rane 133 using epoxy alone, or epoxy in combination with a separate tubular member. Tubing 130 may also form a part of tubing 54. The combination of the polyimide tube 130 with the porous 15 mem~rane 133 within coil 116 reduces the possibility that high velocity jets of liquid will exit coil 116 during a perfusion procedure. Again, this ensures a low velocity, "weeping", atraumatic flow which ~inimi zes the possibility of cavitation or ~u~le formation during the delivery of the 20 oxygen supersaturated fluid, which prevents recoil of catheter, and which minimizes the possibility of damaging, or causing trauma to near~y ~ody tissues.
Referring now to FI&S. 16 and 17, an alternative embodiment of a perfusion guidewire is shown. ~IG.'17 is an 25 enlarged view of circled region 148 in ~IG. 16. In FIGS. 16 and 17, polyimide tube 54 is bonded to tu~e 141 with a layer of epoxy 143. Tube 141 may be made of polyester heat shrink tubing, polyimide tu~ing, or any other suita~le material.
Tube 141 has a plurality of perforations 145. Thus, ~affle 30 126D of perfusion region 125 is formed ~y tu~e 141 which fits over coil 116. In operation, fluid flows out of the windings of coil 116, and then out of perforations 145. Again, windings of coil 116 may be forced apart ~y the hydrostatic pressure of the fluid ~eing delivered, or the windings of 35 coil 116 may ~e pre-tensioned during the fabrication stage.
~ eferring now to ~IG. 18, another alternative em~odiment of distal portion 40 of a perfusion guidewire CA 022~8966 1998-12-22 W 097/49447 PCT~US97/10919 according to the invention is shown. In the embodiment shown in ~I~. 18, spring 116 extends out from the distal end of tube 54 to solder joint 140. Spring 116 includes a perfusion region 125. A second, radiopaque platinum spring or distal 5 coil 42 extends from the distal end of spring 116. Coil 42 is fixed to spring 116 ~y solder joint 140.
In the embodiment shown in FIG. 18, core wire 24 preferably extends past solder joint 140, then tapers and terminates within distal coil 42. A stainless steel ribbon 10 208 is preferably mounted to the distal tip of distal coil 42. The proximal end of ribbon 208 is mounted to the section of core wire 24 just proximal to solder joint 140.
Perfusion region 125 includes a baffle 126E.
Baffle 126~ may take the form of baffles 126A-C, as discussed 15 above with respect to FIGS. 9, 11, and 14. Baffle 126E may also take the form of any appropriate configuration that provides the desired fluid flow characteristics. Baffle 126E
may be open- or close-ended, and may be any desired length that fits within perfusion region 125.
Modifications l~or U~3e In AIlgiography or Angioscopy Applications As was discussed above, the present invention may be used to deliver relatively large quantities of liquid to a 25 desired location without causing trauma to the surrounding tissues, and without causing recoil of the delivery device.
The present invention further allows such large quantities of liquid to be delivered using a relatively low profile (i.e., small diameter) device.
In addition to its usefulness as a perfusion guidewire in angioplasty and similar procedures, the present invention is also well suited for the procedures of angiography and angioscopy. In angiographic procedures, the present invention could be used to deliver contrast material 35 to a site of interest; in angioscopic procedures, the present invention could be used to deliver saline to a site of interest. Again, saline in such procedures is used to CA 022~8966 1998-12-22 W O 97/49447 PCTrUS97110919 displace blood, so that clear images can be made of a vessel wall.
Embodiments of the present invention can be scaled so that appropriate amounts of liquid can be delivered to a 5 desired location. In angiography applications, a perfusion device according to the present invention could have outside diameters ranging from about .5 mm to 3.0 mm (approximately 1.5 to 9 French), with an approximately 1.0 mm (3 French) diameter being the preferred size for ~oth intra-coronary and 10 intra-cerebral angiography applications. This size would accommodate the necessary contrast material volumes for adequate vessel visualization, while assuring minimal invasiveness compared to commercially available, 5 French or larger angiography catheters. Additionally, the guidewire 15 body and tip configuration properties of a perfusion device according to the present invention enable fast and accurate device placement in difficult vessel geometries.
A preferred perfusion device can be connected to commercially available "power injectors" (such as those 20 manufactured by MedRad, Inc. of Pittsburgh, PA), for high pressure, high volume contrast angiography. Because of the rugged construction of the preferred perfusion device, it can tolerate pressures considerably greater than those tolerated by commercially available angiography catheters. This should 25 enable a future generation of even higher pressure power injectors.
Finally, the small size of the perfusion device, compared to commercially available catheters, enables outpatient angiography studies because of the reduced 30 puncture site size and associated complications/concerns with the puncture/insertion site (typically in the leg, arm, or neck).
In angioscopy procedures, a perfusion guidewire of the type discussed above (preferably having an outside 35 diameter of approximately .014", or about 1 French) could ~e combined with the optical bundle of a comm~rcially available angioscope.

CA 022~8966 1998-12-22 Such a combination of a perfusion guidewire and an angioscope could be delivered to a desired location using a 6 French guide catheter, instead of the larger 8 French catheter currently required by the ImageCath~ coronary angioscope discussed above. The high liquid flow rate permitted by the present invention would allow the generation of angioscopic images of similar or better quality than those currently available.

10 ~econfigurable Fl-lid Delivery Device In certain angiography or other applications, it may be desirable to change the shape of the distal end of the fluid delivery device while the delivery device is in vivo.
In such situations, the use of a perfusion guidewire or 1~ device of the type discussed above having fixed core wire and a distal coil with a predefined shape may not provide the desired ability to change shape in mid-procedure.
FIG. 19 shows an alternative embodiment of the present invention including a reconfigurable fluid delivery 20 device 220. Device 220 includes a proximal segment 10 and a distal segment 222.
Proximal segment 10 includes an elongated tube 12 defining a lumen of the type discussed above with respect to FIG. 2. Again, tube 12 may be a stainless steel tu~e coated 25 with PTFE; tube 12 could also be a tube made of polyimide, high density polyethylene, or any high strength polymer or metal (including a non-porous metal spring or braided line) having the appropriate strength and other characteristics required for use during a particular procedure. In 30 angiography applications, tube 12 preferably has about a 3 French (approximately 1.0 mm) outside diameter.
Fluid delivery device 220 differs from the embodiments discussed a3:ove in that there is no transitional region or fixed core wire included in the device. As is 3~ shown in FIG. 20, distal segment 222 preferably includes a coil 1 6 which is attached to the distal end of tube 12. The proximal end of coil 116 may be attached to the distal end of CA 022~8966 1998-12-22 W 097/49447 PCT~US97/10919 tube 12 using any of the attachment techniques discussed above with respect to the several alternative embodiments.
Coil llÇ may also be attached to tube 12 using any other appropriate attachment technique. Portions of coil 116 may 5 be radiopaque if desired.
As in the embodiments discussed above, distal segment 222 preferably includes a perfusion zone 125 and a baffle 126. In the embodiment shown in FI~. 20, distal segment 222 includes a baffle 126B of the type discussed 10 above with respect to FIGS. 11 and 12. However, distal segment 222 could include a baffle 126A of the type discussed above with respect to FIGS. 9 and 10, a baffle 126C of the type discussed above with respect to FIGS. 7 and 8, or any other appropriate baffle which provides the desired reduction 15 in fluid flow velocity. A removable stylet 224 (shown in phantom) could be used to change the shape of the distal segment 222. This feature will be discussed further below.
As is shown in FI~. 19, device 220 is preferably connected to Y-adapter 226 via luer-lock connector 228, both 20 of which are known to those skilled in the art. Contrast material or other desired liquid may ~e pumped into device 220 via port 230 in adapter 226. A stylet 224 may be inserted into device 220 via port 232 in adapter 226.
By advancing a stylet 224 with a predeter~ined size 2~ and shape through device 220, the flexibility and shape of device 220 can ~e altered as needed. During initial passage from a peripheral artery (for example, the radial, brachial, or femoral artery) to an arterial site of interest, distal segment 222 should be quite flexible. Accordingly, a stylet 30 224 having little support should be inserted within the lumen channel of device 220. After reaching the site of interest, the flexible stylet may be replaced with one that provides a suitable shape and stiffness to facilitate engagement of the artery of interest. For example, a stylet having a shape 3~ similar to that used with preformed conventional coronary angiographic catheters could be advanced tQ the distal end of device 220 into a coronary artery. With stylet 224 in place, CA 022~8966 1998-12-22 W O 97/49447 PCTrUS97/10919 contrast material is injected through baffle 126 and into the site of interest. After completion of injections for one coronary artery (or ~ypass graft), stylet 224 can be replaced with another one that allows engagement of a different 5 coronary artery or bypass graft.

~NGIOSCO~Y DEVICE
FIG. 21 shows a distal segment 40 of a preferred fluid delivery device along with an angioscopic optical 10 bundle 250. Again, a perfusion guidewire or fluid delivery device of the type discussed above (preferably having an outside diameter of approximately .014" or about 1 ~rench) could be combined with the optical bundle of a commercially available angioscopic optical bundle. Such a combination of 15 a perfusion guidewire or fluid delivery device and an angioscope could be delivered to a desired location using a 6 French guide catheter 252, instead of the larger 8 French guide catheter currently required by the ImageCath~ coronary angioscope discussed above. The high liquid flow rate 20 permitted by the present invention would allow the generation of angioscopic images of similar or ~etter quality than those currently available.
In FI~. 21, the distal segment of the fluid delivery device or guidewire of FIG. 18 is shown. ~owever, 25 it will be understood that any of the embodiments discussed above could be used in an angioscopy application. Moreover, it will ~e understood that any appropriate image bundle 250 having the desired size and imaging characteristics could be used in combination with the guidewire or fluid delivery 30 device of the present invention.
The present invention has been descri~ed in terms of a preferred embodiment. The invention, however, is not limited to the embodiment depicted and described. ~ather, the scope of the invention is defined by the appended claims.

Claims (26)

WHAT IS CLAIMED IS:
1. A fluid delivery device, comprising:
a tubular housing defining a fluid lumen therethrough, the housing having a proximal portion and a distal portion;
the proximal portion of the tubular housing having a first outside diameter, and the distal portion of the tubular housing having a second outside diameter;
a core wire having a proximal end and a distal end, the proximal end of the core wire being tapered and secured within the fluid lumen to a notch in the proximal portion of the tubular housing;
a first coil mounted at the distal end of the core wire; and an elongated cylindrical sheath extending from the distal portion of the tubular housing and over a portion of the core wire, the sheath defining a continuation of the fluid lumen and having at least one fluid exit in the form of a porous baffle.
2. A fluid delivery device as in claim 1, further comprising a second coil surrounding the cylindrical sheath.
3. A fluid delivery device as in claim 2, wherein the first coil and the second coil surrounding the cylindrical sheath comprise a single coil extending from the tubular housing to the distal end of the fluid delivery catheter.
4. A fluid delivery device as in claim 1 wherein the elongated cylindrical sheath is made of polymer tubing.
5. A fluid delivery device as in claim 4 wherein the distal end of the polymer tubing is open.
6. A fluid delivery device as in claim 4 wherein the distal end of the polymer tubing is sealed.
7. A fluid delivery device as in claim 3 wherein the baffle includes a plurality of perforations.
8. A fluid delivery device as in claim 3 wherein the baffle includes a porous membrane.
9. A fluid delivery device as in claim 8 wherein the porous membrane surrounds a perforated polymer tube.
10. A fluid delivery device as in claim 2 wherein the first coil is radiopaque and the second coil is transparent to x-rays.
11. A fluid delivery device as in claim 10 wherein the first and second coils are fixed together with a solder joint.
12. A fluid delivery device as in claim 11 further including a stainless steel ribbon extending from the distal end of the first coil to the core wire at a location proximal to the solder joint.
13. A fluid delivery device as in claim 1 wherein the fluid delivery device delivers contrast material.
14. A fluid delivery device as in claim 1 wherein the fluid delivery device delivers saline.
15. A fluid delivery device as in claim 1 wherein the fluid delivery device delivers oxygen supersaturated fluid.
16. A fluid delivery device as in claim 1 wherein the first outside diameter is equal to the second outside diameter.
17. A fluid delivery device as in claim 1 wherein the first outside diameter is larger than the second outside diameter.
18. A fluid delivery device, comprising:

a flexible, high pressure tubular housing defining a fluid lumen therethrough, the tubular housing having a proximal end and a distal end;
an elongated cylindrical sheath extending from the distal end of the tubular housing, the sheath defining a continuation of the fluid lumen;
a coil surrounding the cylindrical sheath; and a baffle zone extending along at least a portion of the coil, the baffle zone defining at least one fluid exit and comprising means for creating a flow velocity drop such that fluid perfused through said catheter leaves said fluid exit under atraumatic conditions.
19. The catheter according to claim 18, wherein said flow velocity drop means comprises perforated tubing.
20. The catheter according to claim 18, wherein said flow velocity drop means comprises a permeable membrane.
21. The catheter according to claim 18, wherein said flow velocity drop means comprises perforated tubing surrounded by a permeable membrane.
22. The catheter according to claim 18, wherein the flow velocity drop means provides a velocity drop of at least a factor of five.
23. The catheter according to claim 18, wherein the flow velocity drop means provides an atraumatic fluid exit velocity of less than about 200 cm/sec.
24. The catheter according to claim 18, further including a removable stylet which alters the shape of at least one part of the coil, whereby the coil can engage a vascular site of interest.
25. An angioscopy device, comprising:

a guide catheter;
an angioscopic optical bundle; and a fluid delivery device;
the optical bundle and fluid delivery device at least partially contained within the guide catheter;
wherein the fluid delivery device comprises:
a flexible, high pressure tubular housing defining a fluid lumen therethrough, the tubular housing having a proximal end and a distal end;
an elongated cylindrical sheath extending from the distal end of the tubular housing, the sheath defining a continuation of the fluid lumen;
a coil surrounding the cylindrical sheath; and a baffle zone extending along at least a portion of the coil, the baffle zone defining at least one fluid exit and comprising means for creating a flow velocity drop such that fluid perfused through said catheter leaves said fluid exit under atraumatic conditions.
26. An angioscopy device, comprising:
a guide catheter;
an angioscopic optical bundle; and a fluid delivery device;
the optical bundle and fluid delivery device at least partially contained within the guide catheter;
wherein the fluid delivery device comprises:
a tubular housing defining a fluid lumen therethrough, the housing having a proximal portion and a distal portion;
the proximal portion of the tubular housing having a first outside diameter, and the distal portion of the tubular housing having a second outside diameter;
a core wire having a proximal end and a distal end, the proximal end of the core wire being tapered and secured within the fluid lumen to a notch in the proximal portion of the tubular housing;

a first coil mounted at the distal end of the core wire; and an elongated cylindrical sheath extending from the distal portion of the tubular housing and over a portion of the core wire, the sheath defining a continuation of the fluid lumen and having at least one fluid exit in the form of a porous baffle.
CA002258966A 1996-06-24 1997-06-19 High pressure transluminal fluid delivery device Abandoned CA2258966A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/669,662 US5957899A (en) 1995-11-27 1996-06-24 High pressure transluminal fluid delivery device
US08/669,662 1996-06-24

Publications (1)

Publication Number Publication Date
CA2258966A1 true CA2258966A1 (en) 1997-12-31

Family

ID=24687215

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002258966A Abandoned CA2258966A1 (en) 1996-06-24 1997-06-19 High pressure transluminal fluid delivery device

Country Status (6)

Country Link
US (2) US5957899A (en)
EP (1) EP0917479A4 (en)
JP (1) JP2001500751A (en)
AU (1) AU714589B2 (en)
CA (1) CA2258966A1 (en)
WO (1) WO1997049447A1 (en)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607698B1 (en) * 1997-08-15 2003-08-19 Therox, Inc. Method for generalized extracorporeal support
US6676900B1 (en) 1994-12-09 2004-01-13 Therox, Inc. Method for the preparation and delivery of gas-enriched fluids
US6235007B1 (en) * 1995-11-27 2001-05-22 Therox, Inc. Atraumatic fluid delivery devices
US20040099523A1 (en) * 1996-12-04 2004-05-27 Otec Research Inc. Catalytic simulation using radio frequency waves
AU5218898A (en) 1996-12-04 1998-06-29 Oxy L'eau Inc. Catalytic resonance simulator
US5944750A (en) * 1997-06-30 1999-08-31 Eva Corporation Method and apparatus for the surgical repair of aneurysms
JP3748511B2 (en) * 1997-09-29 2006-02-22 ボストン・サイエンティフィック・サイメド・インコーポレイテッド Image guide wire
US6078831A (en) * 1997-09-29 2000-06-20 Scimed Life Systems, Inc. Intravascular imaging guidewire
US6295990B1 (en) 1998-02-03 2001-10-02 Salient Interventional Systems, Inc. Methods and systems for treating ischemia
US6622367B1 (en) 1998-02-03 2003-09-23 Salient Interventional Systems, Inc. Intravascular device and method of manufacture and use
US6602467B1 (en) 1998-07-24 2003-08-05 Therox, Inc. Apparatus and method for blood oxygenation
US8506519B2 (en) 1999-02-16 2013-08-13 Flowcardia, Inc. Pre-shaped therapeutic catheter
US6855123B2 (en) 2002-08-02 2005-02-15 Flow Cardia, Inc. Therapeutic ultrasound system
US7004923B2 (en) * 1999-07-19 2006-02-28 I-Flow Corporation Catheter for uniform delivery of medication
US7547302B2 (en) 1999-07-19 2009-06-16 I-Flow Corporation Anti-microbial catheter
US7452353B2 (en) * 1999-07-19 2008-11-18 I-Flow Corporation Catheter for uniform delivery of medication
US6350253B1 (en) * 1999-07-19 2002-02-26 I-Flow Corporation Catheter for uniform delivery of medication
US7510550B2 (en) * 1999-07-19 2009-03-31 I-Flow Corporation Catheter for uniform delivery of medication
US6890482B2 (en) 1999-09-30 2005-05-10 Therox, Inc. Apparatus for blood oxygenation
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6759008B1 (en) 1999-09-30 2004-07-06 Therox, Inc. Apparatus and method for blood oxygenation
US6387324B1 (en) 1999-09-30 2002-05-14 Therox, Inc. Apparatus and method for blood oxygenation
WO2001070322A1 (en) 2000-03-24 2001-09-27 Stephen Brushey Anesthesia conduction catheter
DE10018424A1 (en) * 2000-04-13 2001-10-25 Impella Cardiotech Ag Dilation device for coronary vessel has high pressure pump connected to main lobe for generating pressure and to fluid source that delivers artificial blood product enriched with oxygen
WO2001093470A1 (en) * 2000-05-26 2001-12-06 British Telecommunications Public Limited Company Test signalling
US6582387B2 (en) 2001-03-20 2003-06-24 Therox, Inc. System for enriching a bodily fluid with a gas
US6613280B2 (en) 2001-03-20 2003-09-02 Therox, Inc. Disposable cartridge for producing gas-enriched fluids
US20060064071A1 (en) * 2001-11-06 2006-03-23 Possis Medical, Inc. Gas inflation/evacuation system incorporating a reservoir and removably attached sealing system for a guidewire assembly having an occlusive device
US6932828B2 (en) * 2001-11-06 2005-08-23 Possis Medical, Inc. Guidewire occlusion system utilizing repeatably inflatable gas-filled occlusive device
DE60233351D1 (en) * 2001-11-06 2009-09-24 Medrad Inc GUIDING WIRE OCCLUSION SYSTEM WITH REPLAY OF FILLABLE GAS-FILLED OCCLUSION DEVICE
US8133236B2 (en) 2006-11-07 2012-03-13 Flowcardia, Inc. Ultrasound catheter having protective feature against breakage
US9955994B2 (en) 2002-08-02 2018-05-01 Flowcardia, Inc. Ultrasound catheter having protective feature against breakage
US6929635B2 (en) * 2002-08-20 2005-08-16 Scimed Life Systems, Inc. Reinforced multi-lumen medical shaft
US6942677B2 (en) 2003-02-26 2005-09-13 Flowcardia, Inc. Ultrasound catheter apparatus
US7220233B2 (en) 2003-04-08 2007-05-22 Flowcardia, Inc. Ultrasound catheter devices and methods
US7137963B2 (en) 2002-08-26 2006-11-21 Flowcardia, Inc. Ultrasound catheter for disrupting blood vessel obstructions
US7335180B2 (en) 2003-11-24 2008-02-26 Flowcardia, Inc. Steerable ultrasound catheter
US7604608B2 (en) 2003-01-14 2009-10-20 Flowcardia, Inc. Ultrasound catheter and methods for making and using same
US20040088038A1 (en) * 2002-10-30 2004-05-06 Houdin Dehnad Porous metal for drug-loaded stents
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
EP1435253B1 (en) 2002-12-31 2007-01-17 Abbott Laboratories Vascular Enterprises Limited Catheter having a more flexible part between shaft and tip and method of manufacturing thereof
US7182735B2 (en) * 2003-02-26 2007-02-27 Scimed Life Systems, Inc. Elongated intracorporal medical device
US7303533B2 (en) * 2003-04-10 2007-12-04 Intraluminal Therapeutics, Inc. Shapeable intraluminal device and method therefor
WO2004101052A2 (en) * 2003-05-12 2004-11-25 I-Flow Corporation Catheter for uniform delivery of medication
US7341630B1 (en) * 2003-06-26 2008-03-11 Advanced Cardiovascular Systems, Inc. Stent coating system
US7758510B2 (en) 2003-09-19 2010-07-20 Flowcardia, Inc. Connector for securing ultrasound catheter to transducer
US7625353B2 (en) 2004-05-27 2009-12-01 Abbott Laboratories Catheter having first and second guidewire tubes and overlapping stiffening members
US7628769B2 (en) 2004-05-27 2009-12-08 Abbott Laboratories Catheter having overlapping stiffening members
US7658723B2 (en) 2004-05-27 2010-02-09 Abbott Laboratories Catheter having plurality of stiffening members
US7815627B2 (en) * 2004-05-27 2010-10-19 Abbott Laboratories Catheter having plurality of stiffening members
US7794448B2 (en) 2004-05-27 2010-09-14 Abbott Laboratories Multiple lumen catheter and method of making same
US7785318B2 (en) 2004-05-27 2010-08-31 Abbott Laboratories Catheter having plurality of stiffening members
US7785439B2 (en) 2004-09-29 2010-08-31 Abbott Laboratories Vascular Enterprises Limited Method for connecting a catheter balloon with a catheter shaft of a balloon catheter
US7527606B2 (en) * 2004-05-27 2009-05-05 Abbott Laboratories Catheter having main body portion with coil-defined guidewire passage
US7540852B2 (en) 2004-08-26 2009-06-02 Flowcardia, Inc. Ultrasound catheter devices and methods
US8221343B2 (en) 2005-01-20 2012-07-17 Flowcardia, Inc. Vibrational catheter devices and methods for making same
US20060258981A1 (en) * 2005-04-27 2006-11-16 Tracee Eidenschink Balloon catheter with perfusion lumen
US20090018526A1 (en) * 2005-08-25 2009-01-15 John Melmouth Power Devices and Methods for Perfusing an Organ
US7615031B2 (en) * 2005-09-01 2009-11-10 Medrad, Inc. Gas inflation/evacuation system incorporating a multiple element valved guidewire assembly having an occlusive device
US20070060878A1 (en) 2005-09-01 2007-03-15 Possis Medical, Inc. Occlusive guidewire system having an ergonomic handheld control mechanism and torqueable kink-resistant guidewire
US8608703B2 (en) 2007-06-12 2013-12-17 Medrad, Inc. Infusion flow guidewire system
US20080097294A1 (en) * 2006-02-21 2008-04-24 Possis Medical, Inc. Occlusive guidewire system having an ergonomic handheld control mechanism prepackaged in a pressurized gaseous environment and a compatible prepackaged torqueable kink-resistant guidewire with distal occlusive balloon
US20070129682A1 (en) * 2005-12-02 2007-06-07 Tracee Eidenschink Guidewire with perfusion capability
US9282984B2 (en) 2006-04-05 2016-03-15 Flowcardia, Inc. Therapeutic ultrasound system
US20080236593A1 (en) * 2006-06-22 2008-10-02 Nellcor Puritan Bennett Llc Endotracheal cuff and technique for using the same
US8434487B2 (en) 2006-06-22 2013-05-07 Covidien Lp Endotracheal cuff and technique for using the same
KR100911833B1 (en) * 2006-10-02 2009-08-13 아이-플로우 코포레이션 Catheter for Uniform Delivery of Medication
US8246643B2 (en) 2006-11-07 2012-08-21 Flowcardia, Inc. Ultrasound catheter having improved distal end
US9387308B2 (en) 2007-04-23 2016-07-12 Cardioguidance Biomedical, Llc Guidewire with adjustable stiffness
US20100049167A1 (en) * 2008-08-20 2010-02-25 Cook Incorporated Introducer sheath having reinforced distal taper
US8636952B2 (en) 2008-12-04 2014-01-28 Therox, Inc. System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element
US8246564B2 (en) 2008-12-04 2012-08-21 Therox, Inc. System for enriching a bodily fluid with a gas having automated priming capabilities
US8192384B2 (en) 2008-12-04 2012-06-05 Therox, Inc. System for enriching a bodily fluid with a gas having a dual-function power switch mechanism
US8226566B2 (en) 2009-06-12 2012-07-24 Flowcardia, Inc. Device and method for vascular re-entry
CH701913A1 (en) 2009-09-30 2011-03-31 Schwager Medica Guidewire.
EP2603254A4 (en) 2010-08-12 2016-08-24 Boston Scient Ltd Infusion flow system and fluid coupling
WO2013109269A1 (en) 2012-01-18 2013-07-25 Bard Peripheral Vascular, Inc. Vascular re-entry device
JP6293145B2 (en) 2012-08-02 2018-03-14 バード・ペリフェラル・バスキュラー・インコーポレーテッド Ultrasound catheter system
US20180140321A1 (en) 2016-11-23 2018-05-24 C. R. Bard, Inc. Catheter With Retractable Sheath And Methods Thereof
US11596726B2 (en) 2016-12-17 2023-03-07 C.R. Bard, Inc. Ultrasound devices for removing clots from catheters and related methods
US10758256B2 (en) 2016-12-22 2020-09-01 C. R. Bard, Inc. Ultrasonic endovascular catheter
US10582983B2 (en) 2017-02-06 2020-03-10 C. R. Bard, Inc. Ultrasonic endovascular catheter with a controllable sheath

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599296A (en) * 1991-02-14 1997-02-04 Wayne State University Apparatus and method of delivery of gas-supersaturated liquids
US4793350A (en) * 1987-01-06 1988-12-27 Advanced Cardiovascular Systems, Inc. Liquid filled low profile dilatation catheter
US4964409A (en) * 1989-05-11 1990-10-23 Advanced Cardiovascular Systems, Inc. Flexible hollow guiding member with means for fluid communication therethrough
FR2671283B1 (en) * 1991-01-08 1995-05-12 Alain Durand INTRAVASCULAR MULTI-LIGHT CATHETER, LIKELY TO BE IMPLANTED WITH TUNNELLING.
US5605162A (en) * 1991-10-15 1997-02-25 Advanced Cardiovascular Systems, Inc. Method for using a variable stiffness guidewire
AU5672194A (en) * 1992-11-18 1994-06-22 Spectrascience, Inc. Apparatus for diagnostic imaging
US5322508A (en) * 1993-04-08 1994-06-21 Cordis Corporation Guidewire fluid delivery system and method of use
US5409470A (en) * 1993-05-07 1995-04-25 C. R. Bard, Inc. Dilatation catheter and guidewire with threaded tip connection
US5797876A (en) * 1995-11-27 1998-08-25 Therox, Inc. High pressure perfusion device

Also Published As

Publication number Publication date
US6123698A (en) 2000-09-26
AU3500297A (en) 1998-01-14
WO1997049447A1 (en) 1997-12-31
EP0917479A4 (en) 2000-09-27
JP2001500751A (en) 2001-01-23
AU714589B2 (en) 2000-01-06
EP0917479A1 (en) 1999-05-26
US5957899A (en) 1999-09-28

Similar Documents

Publication Publication Date Title
US5957899A (en) High pressure transluminal fluid delivery device
US5976119A (en) High pressure perfusion device
WO1997049447A9 (en) High pressure transluminal fluid delivery device
WO1997019713A9 (en) High pressure perfusion device
US6235007B1 (en) Atraumatic fluid delivery devices
US5201754A (en) Balloon dilatation catheter with varying radiopacity
EP0564894B1 (en) Rapid exchange catheter system
US5902290A (en) Catheter providing intraluminal access
US5843051A (en) Intravascular device for coronary heart treatment
US8105259B2 (en) Catheter
EP0513818A1 (en) Low profile diltation catheter
EP0650740A1 (en) Interventional catheter
JPH02224767A (en) Operable type expansion cathetel
WO1993020882A1 (en) Low profile dilatation catheter
US20070106245A1 (en) Infusion guidewire
CN113546287A (en) Balloon dilatation catheter
CN215780888U (en) Balloon dilatation catheter
JPH10290841A (en) Micro-catheter
JPH0751375A (en) Baloon catheter for angioplasty

Legal Events

Date Code Title Description
FZDE Dead